HomeHealthcare & Life SciencesBiotechnology Microbial Transglutaminase Market

Taiwan Microbial Transglutaminase Market Size & Outlook, 2025-2033


Taiwan Microbial Transglutaminase Market Insights

  • Based on Reed Intelligence findings, the Taiwan Microbial Transglutaminase Market reached USD 2.57 Million in 2024 and is estimated to attain USD 6.15 Million by 2033.
  • From 2026 to 2033, the Taiwan market is expected to grow at a steady CAGR of 10.14%.
  • Within the By Source category, Streptomyces Mobaraense dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Streptoverticillium Hygroscopicus is forecasted to deliver the fastest growth, positioning it as the most lucrative By Source segment.

Other Key Findings


  • Taiwan contributed 1.88% to the global Microbial Transglutaminase Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Microbial Transglutaminase Market.
  • In Asia Pacific, China is projected to capture the leading share of market size by 2033.
  • Among Asia Pacific markets, China is expected to post the fastest growth, reaching USD 36.3 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 2.57 Million
Market Size In 2033 USD 6.15 Million
Largest segment Streptomyces Mobaraense
Units Revenue in USD Million
CAGR 10.14% (2025-2033)
Segmnetation Covered
By Source
  1. Streptomyces Mobaraense
  2. Streptoverticillium Griseocarneum
  3. Streptoverticillium Hygroscopicus
  4. Others
By Form
  1. Powder
  2. Liquid
By End-Use Industry
  1. Food & Beverage
  2. Pharmaceuticals
  3. Cosmetics
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports